European Medicines Agency Withheld Authorization for Novavax COVID XBB1.5 vaccine
FDA did authorize it--but don't take it, as there must be a significant problem
Don’t take any of them. The side effects increase with the number of doses. As does the mortality rate. COVID vaccines increase your risk of dying, by a lot.
And Igor Cudov has noted that Pfizer’s stock price is down — a lot, 25% less than before the pandemic. The crowd is speaking. And only 2% or less of Americans are still bedazzled by the propaganda about these vaccines, and only 2% or less have received the new XBB version.
https://www.fiercepharma.com/pharma/pharma-regulatory-tracker-2023
UPDATED: Monday, October 16 at 8:15 a.m.
Novavax has encountered a setback in its attempt to win market authorization for its updated COVID-19 vaccine in Europe, The Financial Times reports.
The European Medicines Agency was set to decide on approving the vaccine by Friday, but it instead sent the filing back to Novavax with a request for more information.
A Novavax spokesperson told FT that the company is responding “expeditiously.” Two weeks ago, Novavax won FDA authorization for its updated vaccine in people 12 and older.
-
I am in JFK airport, waiting for a flight home after grueling travels to Sweden, Utah and Alaska in the last 18 days.